![Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial - The Lancet Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/dc0fca29-f6aa-425e-adf7-0b5b1d188aee/gr1_lrg.gif)
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial - The Lancet
![Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/42b7004d-c481-405d-8d94-441838b60ddf/jah32384-fig-0001.gif)
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association
![Frontiers | Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis | Pediatrics Frontiers | Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis | Pediatrics](https://www.frontiersin.org/files/Articles/447206/fped-07-00374-HTML-r1/image_m/fped-07-00374-g001.jpg)
Frontiers | Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis | Pediatrics
![PDF) Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease PDF) Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease](https://i1.rgstatic.net/publication/259920812_Clinical_characteristics_of_hemophagocytic_lymphohistiocytosis_following_Kawasaki_disease_differentiation_from_recurrent_Kawasaki_disease/links/5486ac490cf289302e2c14ad/largepreview.png)
PDF) Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease
![The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan - International Journal of Cardiology The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4eec1212-396a-4b93-bffb-f2bd95490966/gr1.jpg)
The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan - International Journal of Cardiology
![Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease - International Journal of Cardiology Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f2ecc9d7-562c-4156-80f7-3d4f76fbde78/gr1.jpg)
Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease - International Journal of Cardiology
Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram
![Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML](https://www.mdpi.com/medicina/medicina-56-00145/article_deploy/html/images/medicina-56-00145-g001.png)
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML
![Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-59972-7/MediaObjects/41598_2020_59972_Fig1_HTML.png)
Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports
![Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature | Italian Journal of Pediatrics | Full Text Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature | Italian Journal of Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13052-021-01041-4/MediaObjects/13052_2021_1041_Fig1_HTML.png)
Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature | Italian Journal of Pediatrics | Full Text
![While relatively rare, Kawasaki disease can be mistaken for other ailments and can damage heart if not treated - pennlive.com While relatively rare, Kawasaki disease can be mistaken for other ailments and can damage heart if not treated - pennlive.com](https://www.pennlive.com/resizer/z4YcJlja49bEqgwPlWFiQWGkX54=/1280x0/smart/advancelocal-adapter-image-uploads.s3.amazonaws.com/image.pennlive.com/home/penn-media/width2048/img/bodyandmind_impact/photo/kdposterjpg-e6b76ddef1692ad1.jpg)
While relatively rare, Kawasaki disease can be mistaken for other ailments and can damage heart if not treated - pennlive.com
![Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13052-021-00962-4/MediaObjects/13052_2021_962_Fig1_HTML.png)
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
PLOS ONE: Comparative Effectiveness of Intravenous Immunoglobulin for Children with Kawasaki Disease: A Nationwide Cohort Study
![Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience - The Journal of Pediatrics Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience - The Journal of Pediatrics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/88e2db39-bb91-4c96-9d8c-45111df04ab2/ympd10178-fig-0001.jpg)